ONCOGENEX PHARMACEUTICALS, INC. 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed May 27, 2016
Insider Transaction Report
Form 4
MATTINGLY MARTIN A
Director
Transactions
- Award
Stock Option (right to buy)
2016-05-26+22,500→ 22,500 totalExercise: $1.00Exp: 2026-05-26→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The options vest 100% on the earlier of May 26, 2017 or the date immediately prior to the issuer's next annual meeting of stockholders.